Dr. Rouce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
301 University Blvd
Galveston, TX 77555Phone+1 409-772-4194
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- University of Texas Medical Branch HospitalsResidency, Pediatrics, 2007 - 2010
- University of Texas Medical Branch School of MedicineClass of 2007
Certifications & Licensure
- TX State Medical License 2010 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen Start of enrollment: 2017 Nov 01
- Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells Start of enrollment: 2021 Aug 02
- CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA) Start of enrollment: 2022 Jun 01
Publications & Presentations
PubMed
- American Society of Hematology: building a comprehensive minority recruitment and retention professional program.Margo R Rollins, Rahma M Warsame, Melody Smith, Arturo Molina, Rayne H Rouce
Blood Advances. 2024-12-24 - EBV and post-transplant lymphoproliferative disorder: a complex relationship.Nader Kim El-Mallawany, Rayne H Rouce
Hematology. American Society of Hematology. Education Program. 2024-12-06 - 1 citationsProceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.Jeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, Sarah Wall, Nandita Khera
Transplantation and Cellular Therapy. 2024-12-01
Journal Articles
- EBV/LMP-specific T Cells Maintain Remissions of T and B Cell EBV Lymphomas After Allogeneic Bone Marrow TransplantationStephen Gottschalk, Rayne Rouce, Catherine M Bollard, Malcolm K Brenner, Helen E Heslop, Blood
Abstracts/Posters
- Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell MalignanciesClinically Relevant AbstractRayne H. Rouce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative DisordersRayne H. Rouce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Are We There Yet? A Cancer Cure May Be Just a CAR Ride AwayNational Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/28/2019
- BMT Peds and Adult61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Cell Therapy Pioneer: Modality Could Be Solution to ‘Pretty Large Cadre’ of DiseasesOctober 17th, 2022
- ‘Swag Worthy’ Doctor Splits Time Between Patients, Rap MusicFebruary 3rd, 2021
- Stand up to Cancer Dream Team Tackles T-cell Lymphoma, Focused on CAR-Based StrategiesJanuary 28th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: